tirzepatide drug mounjaro (tirzepatide): Uses, Side Effects, Dosage & More FDA approves new version of

Roughly 1 in 8 people globally live with obesity, and 70% of that burden falls on low- and middle-income countries (LMICs)

Long-term study results are currently limited, but the following must be considered for shaping the clinical algorithm in GLP-1 RA prescribing: proper indication, the characteristics of the prescribed drug, the patient's psychiatric and somatic history, sociodemographic factors, patient expectations, and especially monitoring of response to rapid weight loss (Figure 1)

G., Tian, R., Wende, A

Originally designed to help treat Type 2 Diabetes, GLP-1 drugs and GLP-1/GIP drugs have become popular even among those without diabetes